Body-mass index and metastatic melanoma outcomes.

Lennon, Hannah; Badrick, Ellena; Sperrin, Matthew; Renehan, Andrew G

Lennon, Hannah; Badrick, Ellena; Sperrin, Matthew; Renehan, Andrew G.

Afiliación

Lennon H; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Badrick E; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Cancer Research Centre, NIHR Manchester Biomedical Research Centre, Manchester M20 4BX, UK.
Sperrin M; Health eResearch Centre, Farr Institute, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Renehan AG; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Manchester Cancer Research Centre, NIHR Manchester Biomedical Research Centre, Manchester M20 4BX, UK. Electronic address: andrew.renehan@manchester.ac.uk.

Lancet Oncol ; 19(5): e225, 2018 05.

Article en En | MEDLINE | ID: mdl-29726384

Asunto(s)

Melanoma; Índice de Masa Corporal; Humanos; Inmunoterapia; Estudios Retrospectivos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Melanoma Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google